CD200 Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesMRC; MOX1; MOX2; OX-2
ProductOrderC
Clone#6E8B11
Entrez GenelD4345
FormulationPurified antibody in PBS with 0.05% sodium azide.
HostMouse
IsotypeIgG2a
ImmunogenPurified recombinant fragment of human CD200 (AA: Extra(56-257)) expressed in E. Coli.
MW31.3kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
WB (Western Blot)1/500 - 1/2000
Sequence
Extra(56-257)
Catalog#: 30688
Inquire
Contact us to order
Images
Western Blot
Figure 1: Western blot analysis using CD200 mAb against human CD200 (AA: Extra(56-257)) recombinant protein. (Expected MW is 48.4 kDa)
Figure 1: Western blot analysis using CD200 mAb against human CD200 (AA: Extra(56-257)) recombinant protein. (Expected MW is 48.4 kDa)
Western Blot
Figure 2: Western blot analysis using CD200 mAb against HEK293 (1) and CD200 (AA: Extra(56-257))-hIgGFc transfected HEK293 (2) cell lysate.
Figure 2: Western blot analysis using CD200 mAb against HEK293 (1) and CD200 (AA: Extra(56-257))-hIgGFc transfected HEK293 (2) cell lysate.
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Product Overview
Description

The protein encoded by this gene is a type-1 membrane glycoprotein, which contains two immunoglobulin domains, and thus belongs to the immunoglobulin superfamily. Studies of the related genes in mouse and rat suggest that this gene may regulate myeloid cell activity and delivers an inhibitory signal for the macrophage lineage in diverse tissues. Multiple alternatively spliced transcript variants that encode different isoforms have been found for this gene.

References (references)
References (references)1. Mod Pathol. 2012 Dec;25(12):1637-43.
2. Am J Surg Pathol. 2011 Jan;35(1):76-83.